IMPACT after 17 years: Lessons learned about successful networking
- PMID: 19436462
- PMCID: PMC2661333
- DOI: 10.1093/pch/14.1.33
IMPACT after 17 years: Lessons learned about successful networking
References
-
- Scheifele DW, Halperin SA, members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program Active (IMPACT) Immunization Monitoring Program, ACTive: A model of active surveillance of vaccine safety. Semin Pediatr Infect Dis. 2003;14:213–9. - PubMed
-
- Moore DL, Le Saux N, Scheifele D, Halperin SA, Members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program, ACTive (IMPACT) Lack of evidence of encephalopathy related to pertussis vaccine: Active surveillance by IMPACT, Canada, 1993–2002. Pediatr Infect Dis J. 2004;23:568–71. - PubMed
-
- Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S, members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program, ACTive (IMPACT) Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: A report from IMPACT. Pediatrics. 2003;112:e348–53. - PubMed
-
- Jadavji T, Scheifele D, Halperin S, other members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program, ACTive (IMPACT) Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J. 2003;22:119–22. - PubMed
-
- McNicholas A, Galloway Y, Stehr-Green P, et al. Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004–2006. Human Vaccines. 2007;3:196–204. - PubMed
LinkOut - more resources
Full Text Sources